Tildrakizumab Significantly Improves Work Productivity in Moderate to Severe Plaque Psoriasis

Retrieved on: 2023-10-22 18:05:39

Tags for this article:

Click the tags to see associated articles and topics

Tildrakizumab Significantly Improves Work Productivity in Moderate to Severe Plaque Psoriasis. View article details on hiswai:

Excerpt

The drug, an anti-interleukin-23 p19 monoclonal antibody, has been approved for the treatment of moderate to severe plaque psoriasis in adults. While ...

Article found on: www.hcplive.com

View Original Article